Paul Tudor Jones Dexcom Inc Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Dexcom Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 83,700 shares of DXCM stock, worth $5.84 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

83,700

Previous 26,300 218.25%

Holding current value

$5.84 Million

Previous $1.8 Million 306.79%

% of portfolio

0.02%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $2.93 Million - $4.81 Million	38,770 New	38,770 $4.81 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $926,190 - $1.08 Million	8,235 Added 178.17%	12,857 $1.65 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $184,912 - $218,551	-1,778 Reduced 27.78%	4,622 $537,000
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $1.18 Million - $1.71 Million	-13,933 Reduced 68.52%	6,400 $725,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $212,176 - $261,726	-2,779 Reduced 12.02%	20,333 $1.64 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $1.57 Million - $3.07 Million	23,112 New	23,112 $1.72 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $731,001 - $1.01 Million	-7,770 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $496,882 - $622,949	3,826 Added 97.01%	7,770 $4.17 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $420,864 - $564,701	3,944 New	3,944 $2.16 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $229,415 - $271,305	-2,402 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $422,776 - $710,518	-6,745 Reduced 73.74%	2,402 $974,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $32,258 - $51,050	675 Added 7.97%	9,147 $2.46 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $310,244 - $485,360	8,472 New	8,472 $1.85 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $94,616 - $116,639	-2,663 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $399,281 - $558,190	-14,342 Reduced 84.34%	2,663 $399,000
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $586,943 - $798,343	-20,910 Reduced 55.15%	17,005 $2.03 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $517,020 - $715,859	19,156 Added 102.12%	37,915 $4.54 Million
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $522,689 - $821,977	-22,385 Reduced 54.41%	18,759 $2.68 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $641,543 - $922,446	36,576 Added 800.7%	41,144 $3.91 Million
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $304,115 - $431,722	-23,286 Reduced 83.6%	4,568 $339,000
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $309,736 - $428,394	27,854	27,854 $1.6 Million

Others Institutions Holding DXCM

# of Institutions

1,104

Shares Held

369M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account